The DNA sequence of the ground squirrel hepatitis virus (GSHV) genome predicts the existence of several proteins in addition to the major surface (S) and core antigens. These include the pre-SI and pre-S2 proteins, initiated at sites within the open reading frame preceding and continuous with the coding region for the S gene product, and the X protein, the putative product of an independent reading frame. Using an antibody directed against a peptide predicted by codons 130 to 143 of the pre-SI reading frame, we identified a 43-kilodalton product of the pre-Sl coding region in preparations of GSHV surface antigen purified from the sera of infected animals. In addition, by immunoprecipitation of S-and pre-S-specific in vitro translation products with ground squirrel sera obtained after GSHV infection, we determined that antibodies arise to both S and pre-S determinants. The antibody response to pre-S includes, in some cases, reactivity to pre-Si-specific domains and is not always associated with an anti-S response. Similarly, by production of the viral X gene product in vitro followed by immunoprecipitation with ground squirrel sera, we showed that antibodies to this viral gene product also arise during infection, indicating that X antigenic determinants are synthesized during viral infection and are recognized by the host immune system. Ground squirrel hepatitis virus (GSHV) is a small hepatotropic DNA virus closely related to human hepatitis B virus (HBV) (1, 17, 25). Inoculation of ground squirrels with this agent produces both acute and chronic hepatic infection (7) and provides a useful model system for the study of many aspects of HBV replication. The genome of GSHV has been cloned (6, 29), its nucleotide sequence has been determined (27), and the transcripts it engenders in infected liver cells have been mapped and characterized (2) . These studies allow a more thorough examination of viral genes and their protein products during natural infection of susceptible animal hosts.
Ground squirrel hepatitis virus (GSHV) is a small hepatotropic DNA virus closely related to human hepatitis B virus (HBV) (1, 17, 25) . Inoculation of ground squirrels with this agent produces both acute and chronic hepatic infection (7) and provides a useful model system for the study of many aspects of HBV replication. The genome of GSHV has been cloned (6, 29) , its nucleotide sequence has been determined (27) , and the transcripts it engenders in infected liver cells have been mapped and characterized (2) . These studies allow a more thorough examination of viral genes and their protein products during natural infection of susceptible animal hosts.
Like the genomes of other mammalian hepadnaviruses, the GSHV genome contains four major open reading frames (28) : C, the gene for the viral core (nucleocapsid) proteins; P, the coding region for the viral DNA polymerase; the pre-S/S region, encoding the viral coat proteins (surface antigens); and X, an open reading frame to which no function has been assigned. The products of the viral C and S genes are produced in large quantities in vivo and have been well characterized structurally (3, 4, 8) ; infected animals regularly display prominent immune responses to these proteins (16) . Less is known about the potential products of the GSHV pre-S and X regions, and host responses to these products have not been previously examined.
The organization of the pre-S/S region of GSHV is depicted in Fig. 1A . In HBV, the coding region for the major viral surface antigen is only the distal portion of a much larger open reading frame; the portion 5' to the S region (referred to as pre-S) contains three in-phase AUG codons and thus could encode several larger S-related proteins.
Recent studies of human HBV identified two minor sets of proteins whose synthesis in initiated within the pre-S region; each set is made up of the glycosylated and nonglycosylated derivatives of the same polypeptide (23, 24, 30) . One set, termed pre-S2 proteins, is initiated at the third AUG within codon and appears to be present in higher quantities in intact virions than in the more numerous subviral particles, a fact that may indicate a role in virion morphogenesis (9, 32) .
Because of such suggestions of biological activities unique to pre-S proteins, there is considerable interest in antibody responses to these proteins and their potential significance in the establishment of protective immunity. Such questions may be more readily addressed in studies of animal hepadnaviruses such as GSHV. Earlier studies (4, 26) detected larger polypeptides that are related to the S proteins in sera of GSHV-infected squirrels, but less is known about these proteins, and serologic responses to them have not been characterized.
Still less is known about the GSHV X gene. The X region represents the smallest of the viral open reading frames (ca. 480 base pairs); its predicted protein product is approximately 15 kilodaltons (kDa). No polypeptide of this size has been identified in purified preparations of viral proteins. Serologic responses to HBV X determinants have been noted in human serum, however (10, 18, 21) , and suggestions have been made that such antibodies may be correlated with different stages of infection (18) or pathologic sequelae (21 anti-X antibodies are elicited, indicating that GSHV X determinants must be expressed during natural infection.
MATERIALS AND METHODS DNA constructions. The GSHV genome used in 5ur constructions was that sequenced by Seeger et al. (27) . Restriction enzymes were obtained from New England BioLabs, Inc. Plasmid pSP24G was constructed by inserting the 1.3-kilobase (kb) Sacl GSHV DNA fragment into the Sacl site of the pSP65 (Promega Biotech) polylinker region. The orientations of the resultant clones were determined by restriction endonuclease analysis; clones containing the S coding region downstream from the Salmoniellai bacteriophage SP6 promoter and in the correct transcriptional orientation were selected. Plasmid pSP45G was constructed by first isolating the 2.2-kb EcoRI-BainHI fragment from a GSHV genomic clone whose only PiiII site was replaced with a BainHI linker. This fragment was then inserted into the polylinker region of pSP65. The recombinants obtained were of the proper orientation because of the location of the target restriction sites in the polylinker region. Plasmid pSPCG was constructed by first isolating the 1.1-kb Av'IIPstI fragment containing the GSHV "precore" and core coding region. This fragment was then cloned into the XbaI and PstI sites in the polylinker region of pSP65. The clones obtained were in the correct orientation for transcription of the core gene because of the positions of the target restriction sites in the vector. The construction of pSPXG was done by first isolating the 1.1-kb SacII-PstI fragment containing the GSHV X and precore-core open reading frames. This fragment was then inserted into the polylinker region of pSP65. The recombinants obtained were of the proper orientation because of the positions of the target restriction sites in the polylinker region.
In vitro transcriptions and translations. For in vitro transcription, 1 pg of SP6 promoter-containing plasmid was incubated with 20 U of SP6 polymerase in a 50-pl reaction mixture containing 10 mM Tris (pH 7.5), 10 mM MgCl2, 10 mM spermidine, 50 mM NaCl, the ribonucleotides ATP, GTP, CTP, and UTP (Pharmacia Fine Chemicals) at 2.5 mM each, 20 To further test the reactivity of the antipeptide antisera, plasmid pSP45G was transcribed by SP6 polymerase in the procedure described above. RNA yields were typically in 5-to 10-fold molar excess of the input template. The RNA (1 pig/50 1lI of translation mix) was translated in the procedure described above. Samples (10 [I) of the translation mix were immunoprecipitated as described below.
For immunoaffinity purification, 1 mg of peptide was dissolved in 2 ml of 50 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (pH 7.4) and added to 2 ml of Affi-gel 10 (Bio-Rad Laboratories) that had been previously prepared in accordance with the specifications of the vendor. The slurry was incubated on a platform rocker at 4°C for 12 to 16 h. Unbound peptide was removed by washing the gel with 50 column volumes of TBS. Rabbit sera judged to have high antipeptide antibody titers were pooled to a final volume of 1 ml and incubated with the column material for 1 h at room temperature. After unbound material was allowed to flow through, the columns were washed with 50 column volumes of TBS. Bound material was eluted with 50 ml of 100 mM glycine (pH 2.5), neutralized immediately with 2 M Tris buffer (pH 7.5), and concentrated to 0.5 ml in Amicon-30 microconcentrators (Amicon Corp.) before use.
GSHsAg preparation and radioiodination. Serum (2 ml) from a GSHV-infected ground squirrel was layered over a Biogel A5M column (3 by 150 cm; Bio-Rad) and allowed to flow into the column material until it had entered completely. The flow was then stopped, and the column was filled with 15 ml of A5M column buffer (150 mM NaCl, 50 mM Tris [pH 7 .5], 0.05% aprotinin [Sigma] ) and allowed to run for 48 h at a flow rate of 4 ml/h. Forty 4-ml fractions were collected.
Ground squirrel hepatitis virus surface antigen (GSHsAg)-containing fractions were identified by the AUSRIA radioimmunoassay (Abbott Laboratories). Initial GSHsAgpositive fractions from the column were judged to be 90% pure by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by silver staining. plasmid bearing the pre-S/S region downstream of the bacteriophage SP6 promoter; this mRNA was then subjected to in vitro translation as described in Materials and Methods.
The synthesis of this protein is initiated at the first AUG within pre-S, producing a principal pre-Sl-specific translation product of 43 kDa; some minor products presumed to result from internal initiation at the second and third pre-S AUG were also observed ( Fig. 2A, lane UP) . The antipeptide antibodies were then used to immunoprecipitate the in vitro translation products. Whereas the serum-free and preimmune serum controls showed no reactivity against the translation products ( Fig. 2A, lanes 1 and 2) , these proteins were recognized by both antipeptide antisera ( Fig.  2A, lanes 3 and 4) . As expected, a commercial anti-hepatitis B surface (HBs) antibody was also capable of recognizing the translation products (Fig. 2A, lane 5) . The ability of anti-peptide 2 antibody (lane 3), but not anti-peptide 1 antibody (lane 4), to recognize a doublet suggests that the lower band of this doublet may arise from internal initiation at the second AUG codon of the pre-S region.
These sera were then used to detect pre-SI proteins in preparations of serum-derived GSHsAg. GSHsAg partially purified by column chromatography was concentrated and electrophoresed in a 14% polyacrylamide gel. Corresponding column fractions from a GSHsAg-negative animal were treated in an identical fashion and loaded into an adjacent lane. The resolved proteins were transferred to nitrocellulose and probed with affinity-purified antipeptide antiserum followed by 125I-labeled protein A. Whereas the GSHsAgnegative fraction showed no reactive species (Fig. 2B, lane 2), anti-peptide 2 antibody recognized a polypeptide of 43 kDa (Fig. 2B, lane 1) . Surprisingly, anti-peptide 1 antibody, although able to recognize the in vitro translation products, did not identify a protein species when used under identical conditions (data not shown; see Discussion).
Antibodies to pre-S determinants arise during natural GSHV infection. Recent studies of HBV indicated that at least some pre-S-specific protein determinants may be located on the exterior of sAg-associated particles and virions and that pre-S determinants are highly immunogenic when administered to heterologous hosts in immunization protocols (9, 19, 20) . We sought to determine whether antibodies arise to GSHV pre-S protein domains during natural infection of susceptible hosts. To accomplish this, sera from GSHV-infected squirrels were used in immunoprecipitation assays with radiolabeled pre-S proteins prepared by coupled in vitro transcription and translation. Because all pre-S proteins share the S-specific domains, antibodies arising to either S or pre-S would give indistinguishable results; accordingly, we synthesized pre-S-specific protein fragments by truncation of the pre-S template DNA with appropriate restriction enzymes.
Plasmid pSP45G was cleaved with KpnI to produce a linear molecule truncated 113 nucleotides downstream of the putative translation initiation codon for the GSHV pre-S2 proteins (Fig. 3A) . The short messages produced by SP6-directed in vitro transcription were translated in an in vitro rabbit reticulocyte lysate system to produce a 21-kDa protein fragment representing all of the pre-SI region and containing 33 amino acid residues of pre-S2. With this antigen, convalescent-phase sera from a cohort of 20 animals with documented GSHV infections were tested in immunoprecipitation reactions. The immune precipitates were analyzed by SDS-PAGE; sera taken from the animals before the resolution of infection were used as controls. A representative group of such immunoprecipitations is shown in Fig. 3 . Whereas none of the preresolution sera was reactive, three of four postresolution sera were capable of recognizing GSHV pre-S1/pre-S2 determinants (Fig. 3A, animals 1, 2 , and 4).
To determine whether the presence of anti-pre-S antibodies correlated with an immune response to the products of the GSHV S reading frame, we synthesized GSHV Sspecific protein in vitro by using an SP6-derived vector containing the entire coding region for the GSHV S gene (Fig. 3B) . Immunoprecipitation of the in vitro translation products directed by this plasmid again showed no reactivity with the preresolution sera. Immunoprecipitation with the postresolution sera, however, showed that two of four animals had anti-S antibodies (Fig. 3B, animals 1 and 2) . Surprisingly, one animal with an anti-pre-S response displayed no observable anti-S antibody (Fig. 3B, animal 4) .
The data from a similar analysis of a cohort of 19 animals that had resolved documented GSHV infection are presented in Table 1 . Of 12 anti-S-positive animals, 6 showed an anti-pre-S response. Of the seven anti-S-negative animals, two were anti-pre-S positive.
Antibodies to pre-S1-specific determinants arise during natural infection. We next sought to determine whether GSHV pre-SI determinants elicit an antibody response during natural infection. Plasmid pSP45G was cut with the restriction enzyme FokI. One of the resulting fragments is composed of the SP6 promoter and 364 nucleotides of the pre-Sl open reading frame. The transcripts obtained from the cleaved template were translated as described earlier to yield a 121-amino-acid pre-SI-specific protein fragment (Fig. 4A) . The results of immunoprecipitation with ground squirrel sera that were earlier shown to be reactive to the pre-S1/pre-S2 fragment are shown in Fig. 4B . Four of eight animals with detectable anti-pre-SI/pre-S2 reactivity had anti-pre-Sl reactivity (Fig. 4B, lanes 3, 4, 6 . and 10; Table 1 ). Of these, two were anti-S negative and two were anti-S positive. This demonstrates that the GSHV pre-Sl domains are immunogenic in some animals and that an anti-pre-S response is not necessarily associated with a detectable anti-S response.
Antibodies to determinants specified by the C and X genes Sera from 19 animals were screened for anti-S and anti-pre-S antibodies by using the methods outlined in the text. Anti-S reactivity was determined by immunoprecipitation of an in vitro product of the entire S coding region. Antipre-S reactivity was assayed by immunoprecipitation of an in vitro translation product from the pre-S reading frame prematurely truncated with Kpnl; the primary product was a pre-S-specific polypeptide composed of the entire pre-S1 region and 33 amino acids of pre-S2. Anti-pre-SI reactivity was determined by the ability of sera to immunoprecipitate a pre-Sl-specific polypeptide produced by coupled in vitro transcription and translation of the GSHV pre-S reading frame truncated by FokI; this polypeptide contains 121 amino acids of the pre-Sl region. +, Positive reactivity: -, negative reactivity. arise during natural GSHV infection. We were interested to know whether the above approach could be extended to detect antibodies to putative viral proteins which have not been directly identified. Principal among these is the product of an open reading frame, termed X, which is predicted to be a 15-kDa protein. Accordingly, we performed coupled in vitro transcription and translation of SP6-derived plasmids bearing the intact X open reading frame. Sera obtained from 18 animals after resolution of primary GSHV infection were screened for their ability to immunoprecipitate the radiolabeled X protein. As an internal control, radiolabeled core antigen produced in a similar fashion was included in each precipitation mix; earlier studies with both HBV-and GSHV-infected hosts demonstrated that the majority of infected individuals produce anti-C antibody (32) . Of the 12 anti-C-positive sera, 4 recognized the X gene product at levels significantly above the background levels (Fig. 5.  lanes 13, 14, 15. and 19) ; two additional sera were weakly reactive (lanes 2 and 11). Some sera also precipitated minor translation products of 18 to 20 kDa; these species may represent products of internal translation initiation or premature termination within template GSHV RNA. to have anti-pre-S reactivity were used in immun the pre-Sl-specific polypeptide followed by SDS polyacrylamide gel. The (31) ; the second AUG appears to be abseni hepatitis virus (5, 15) ; and whereas the nuc surrounding the first and third AUGs of G' AUGG and A--AUGA, respectively) makes t efficient initiators of translation, the second unfavorable context (C--AUGA) (11) . We are currently attempting to determine whether the lack of reactivity of -.
anti-peptide 1 5 . Antibodies to the product of GSHV X region arising during natural infection. (A) Production of in vitro translation products of GSHV C and X open reading frames. The GSHV C and X proteins were produced by coupled in vitro transcription and translation as described in the text. The upper panel diagrams the production of the X gene product. The lower panel shows production of the C gene product. (B) Immunoprecipitation of GSHV C and X gene products with sera obtained from animals after natural infection with GSHV. Sera from 18 animals obtained after documented GSHV infection were used in immunoprecipitations of the mixed translation products of the C and X reading frames, followed by SDS-PAGE in a 14% polyacrylamide gel. The gel was then fixed. fluorographed. dried, and exposed to film overnight. The numbers (kilodaltons) at the right indicate the positions of the molecular size markers. Lane UP, Unprecipitated translation mix (the amount loaded represented 5% of the amount used in each immunoprecipitation reaction), lane 16, immunoprecipitation with a preinoculation serum used as a negative control; lanes 1 through 15 and 17 through 19. immunoprecipitations with postresolution sera.
A longer exposure revealed that the sera used in lanes 2 and 11 were also reactive against the X-specific region.
peptides predicted by the HBV X coding region in sera of patients infected with HBV (21) . Furthermore, these investigators suggested a serologic correlation between an anti-X response and the presence of liver cirrhosis or hepatocellular carcinoma or both. Recent studies (10. 18) with bacterial fusion proteins containing X sequences also showed that anti-X antibodies are present in sera from HBV patients.
We demonstrated that in a cohort of 18 animals which had recovered from primary GSHV infection, 6 generated an antibody response to the GSHV X protein and this response was usually associated with a high anti-C titer. This number is likely to represent a minimal estimate for the prevalence of such antibodies in convalescent-phase sera because in the same experiment only ca. 70% of the infected animals displayed anti-C responses with this technique; Marion and colleagues previously demonstrated that virtually all infected squirrels have anti-C antibodies when tested by radioimmunoassay (16) . This disparity may be due to the nature of the test antigen or to the requirement in our system for protein A binding by the antibody. Interestingly, in a comparable study of anti-X antibody in human HBV infection, Meyers et al. (18) observed anti-X responses in onethird of HBsAg-positive sera but only rarely in convalescentphase sera after resolution of HBs antigenemia. These differences may reflect different assay techniques or speciesspecific features of viral infection.
Our data provide strong circumstantial evidence for the synthesis of GSHV X determinants at some stage of viral infection. The frequency with which anti-X antibody arises after uncomplicated GSHV infection suggests that it is 
